Organogenesis Holdings Sees FY24 Revenue $445M-$470M Vs $455.850M Est.
Portfolio Pulse from Benzinga Newsdesk
Organogenesis Holdings has provided its revenue guidance for FY24, projecting a range of $445 million to $470 million, compared to the analyst estimate of $455.850 million.
August 08, 2024 | 9:55 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Organogenesis Holdings has issued its revenue guidance for FY24, forecasting between $445 million and $470 million, which is in line with the analyst estimate of $455.850 million.
The revenue guidance provided by Organogenesis Holdings is within the range of the analyst estimate, suggesting stability in expected performance. This is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100